Safety and Feasibility of ExoNET

Launched by SHIRLEY RYAN ABILITYLAB · Dec 17, 2021

Keywords

ClinConnect Summary

The ExoNET trial is studying a special robotic device designed to help people recover movement in their arms after having a stroke. This device aims to make it easier for patients to practice moving their arms by providing support against gravity. The study is specifically looking at people who have had a stroke for at least eight months and still have some ability to move their shoulders and elbows, but who have moderate difficulty using their arms.

To be eligible for this trial, participants should be aged 65 to 74 and have had either an ischemic stroke (caused by a blocked blood vessel) or a hemorrhagic stroke (caused by bleeding in the brain). They should also have some medical records available that show details about their stroke. If someone has severe arm stiffness, pain, or other cognitive issues that might affect their participation, they would not be able to join the study. Participants in this trial can expect to use the ExoNET device in a supportive environment, which may help them improve their arm movements over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Ischemic or hemorrhagic stroke (8 months post stroke)
• • 2. Available medical records and radiographic information about lesion locations
• • 3. Hemiparesis
• • 4. Some degree of both shoulder and elbow movement capability
• • 5. A "moderate" impairment (Fugl-Meyer score between 15-50)
• Exclusion Criteria:
• • 1. Individuals under the age of 18
• • 2. Bilateral paresis
• • 3. Shoulder pain and/or articular rigidity on the upper limb joint
• • 4. Spasticity (Modified Ashworth Scale of 2)
• • 5. Botox injection to the affected upper extremity within the previous 4 months
• • 6. Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment